1469MO Liver resection versus continued atezolizumab plus bevacizumab (atezo/bev) in locally advanced hepatocellular carcinoma (HCC) after atezo/bev treatment (TALENTop): A multicenter, open-label, randomized phase III trial

Hui‐Chuan Sun, Xiao‐Dong Zhu, Tianfu Wen et al.|Annals of Oncology|2025

Cited by 3